Tag: health care

Pressmeddelanden

Gothenburg research to China - New discoveries from Gothenburg may improve the implants of the future

2012-06-08 11:32 New discoveries concerning how stem cells communicate may improve the chances of using implants. A large delegation of prominent Gothenburg researchers (Sweden) in the fields of stem cells and implants were invited to present their latest research results at the 9th World Biomaterials Congress 2012, which took place from 1 to 5 June in Chengdu, China.

Göteborgsforskning till Kina - Nya upptäckter från Göteborg kan förbättra framtidens implantat

2012-05-30 20:43 Göteborgsforskning till Kina - Nya upptäckter om hur stamceller kommunicerar kan förbättra möjligheterna att använda implantat. En större delegation framstående forskare inom biomaterialområdet är inbjudna till världskongressen för biomaterial i Chengdu, Kina den 1-5 juni för att presentera sina senaste forskningsresultat. GöteborgBIO och BIOMATCELL samarrangerar medverkan i Chengdu.

Process för öppen innovation till Västra Götalandsregionen

2012-03-20 11:00 Ett samarbetsavtal som ska intensifiera ansträngningarna med att överbrygga gapet mellan grundforskning, klinisk tillämpning och industriell produktutveckling har ingåtts mellan Uppsala BIO och GöteborgBIO. Samarbetet gäller BIO-X™, den modell för öppen innovation som Uppsala BIO utvecklat framgångsrikt under flera år och som nu blir tillgänglig för forskare i hela Västra Götalandsregionen.

Visa alla 8 pressmeddelanden »

Nyheter

Albireo AB signes license agreement with Ferring

2012-07-05 11:01 Albireo AB signes license agreement with Ferring, giving Ferring rights to develop and commercialise elobixibat, a first-in-class compound for chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). This is one of the biggest investments made by Ferring for licensing rights.

CYTO365 and Velit Biologics on top at regional Venture Cup Väst final

2012-05-16 14:09 CYTO365 won the “Best business plan"-award, at the Venture Cup Väst (West) regional final held in Gothenburg on 10 May. The company has patented a safe new valve, “CYTO365", which prevents thrombosis and air embolism in patients during chemotherapy treatment.Velit Biologics, develops SB101, a new cancer drug which chokes tumours by cutting off their nutrients via blood vessels.

Diabetes drug can prevent heart disease

2012-03-16 14:29 The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy. Researchers at the University of Gothenburg's Sahlgrenska Academy have shown in a preliminary study in rats that one of the most common diabetes drugs, metformin, also has a protective effect on the heart.

Visa alla 59 nyheter »

Bilder

Immunicum enrolls the first patient in its COMBIG clinical phase I/II-trial in renal cell carcinoma.

2012-03-12 09:26 In total, 12 patients with metastasis cancer of the kidney are being treated in order to investigate possible side effects and the antitumour effect of the vaccine. "“We are looking forward to the study and hope that a future kidney cancer vaccine will help a large number of people that cannot be effectively helped today," says Jamal El-Mosleh, Immunicum´s CEO.

Iris Öhrn

2012-01-13 00:03 Iris Öhrn, Investment Manager Life Science at Business Region Göteborg

Anna-Carin Olin

2012-01-06 09:12 Anna-Carin Olin, Senior Lecturer, Sahlgrenska University Hospital

Visa alla 14 bilder »

Dokument

Programblad - MEDICINTEKNIK: Från idé till marknadsintroduktion - samverkan för framgång 9 nov 2011

2011-10-24 15:47 För att effektivisera processer, undanröja hinder och minska tiden till marknadsintroduktion för medicintekniska innovationer krävs att sjukvården, myndigheter och kontrollorgan samverkar på bästa sätt. Med målet att belysa dessa processer och skapa en gemensam syn på hur vi kan samverka arrangerar GöteborgBIO den 9 november en temadag tillsammans med ForValue i Göteborg. Med företagsutställning.

Programme "Life Science in Focus - Areas of Strenght" March 9, 2011

2011-03-01 10:15 Five areas (Biomaterials/Cell Therapy, Diabetes/Obesity, Neuro, Vaccine and Signal Processing/Visualization) have been analyzed and assessments in terms of scientific strength and industrial activity will be reported.We will get an insight into how one of the global life science-companies in the region, Mölnlycke Health Care AB, deals with innovation strategies and international growth.

NanoTechnology for Biotech Applications - Seminar Programme Feb 10, 2011, Gothenburg

2011-02-06 14:47 Seminar program for the seminar "NanotTechnology for Biotech Applications" arranged on Thursday February 10, 2011 by GöteborgBIO and Nano Connect Scandinavia. Keynote speaker: Prof. Fredrik Höök, Chalmers, Gothenburg.

Visa alla 8 dokument »